Mona M. Wang
Singapore, Singapore
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
A Novel Manual "Centrifuged-Enhanced" Cytosmear Technique for Improving Hypocellular Cytology in the Diagnosis of Vitreoretinal Lymphoma.
Journal: Translational vision science & technology
Published: November 12, 2025
Genetic landscape of uveal melanoma in Southeast Asia: high 1q gains and unique patterns of metastasis risk.
Journal: Eye and vision (London, England)
Published: October 04, 2024
Epigenetic control of CD1D expression as a mechanism of resistance to immune checkpoint therapy in poorly immunogenic melanomas.
Journal: Frontiers in immunology
Published: January 27, 2023
Resistance to immune checkpoint therapies by tumour-induced T-cell desertification and exclusion: key mechanisms, prognostication and new therapeutic opportunities.
Journal: British journal of cancer
Published: December 21, 2022
Applying Single-Cell Technology in Uveal Melanomas: Current Trends and Perspectives for Improving Uveal Melanoma Metastasis Surveillance and Tumor Profiling.
Journal: Frontiers in molecular biosciences
Published: September 29, 2020
Cytologic and Molecular Diagnostics for Vitreoretinal Lymphoma: Current Approaches and Emerging Single-Cell Analyses.
Journal: Frontiers in molecular biosciences
Published: September 28, 2020
Single B-Cell Genomic Analyses Differentiate Vitreoretinal Lymphoma from Chronic Inflammation.
Journal: Ophthalmology
Published: May 29, 2020
PreservCyt Is an Optimal Fixative that Permits Cytologic and Molecular Analyses of Vitreoretinal Lymphoma Biopsies.
Journal: Ocular immunology and inflammation
Published: August 17, 2019
Showing 1-10 of 10
Last Updated: 09/26/2026